Zacks Investment Research on MSN
J&J strikes drug pricing deal with Trump, gets tariff reprieve
Johnson & Johnson JNJ recently signed a landmark agreement with the Trump administration to lower drug prices in the United ...
Five months ago, J&J also revealed its plan to spend $2 billion over the next 10 years to operate a 160,000-square-foot ...
Johnson & Johnson said late Thursday it will lower prices for certain prescription drugs and match the rates in other ...
Most Americans likely will not benefit immediately from efforts to lower prescription prices. Administration officials expect ...
The deals tout significant discounts for people who pay out of pocket for certain medications. But most people with insurance ...
Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller ...
Global drugmakers face a battle in 2026 to secure higher prices for their prescription medicines in Europe after agreeing to ...
The United States and the United Kingdom reached an agreement in principle on pharmaceutical pricing. The update comes as part of the U.S.–U.K. Economic Prosperity Deal (EPD), announced Dec. 1. The ...
Merck is in talks to buy cancer drug developer Revolution Medicines in a deal that may be worth $28 billion to $32 billion ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results